Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

PURPOSE: We initiated a personalized medicine program in the context of early clinical trials, using targeted agents matched with tumor molecular aberrations. Herein, we report our observations. PATIENT AND METHODS: Patients with advanced cancer were treated in the Clinical Center for Targeted Thera...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Tsimberidou, Apostolia-Maria, Iskander, Nancy G., Hong, David S., Wheler, Jennifer J., Falchook, Gerald S., Fu, Siqing, Piha-Paul, Sarina, Naing, Aung, Janku, Filip, Luthra, Rajyalakshmi, Ye, Yang, Wen, Sijin, Berry, Donald, Kurzrock, Razelle
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454458/
https://ncbi.nlm.nih.gov/pubmed/22966018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-1627
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires